A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma

Tremendous progress has been made in development of immunotherapeutic approaches for treatment of bladder urothelial carcinoma (BLCA). However, efficacy and safety of these approaches remain unsatisfactory, necessitating further investigations for identification of indicators for predicting prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chengbang, Chen, Shaohua, Li, Songheng, Mi, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896886/
https://www.ncbi.nlm.nih.gov/pubmed/35251120
http://dx.doi.org/10.3389/fgene.2022.708003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896886/
https://www.ncbi.nlm.nih.gov/pubmed/35251120
http://dx.doi.org/10.3389/fgene.2022.708003

Ejemplares similares